A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation

Completed · Not applicable

Conditions studied: Atrial Fibrillation

In brief

The purpose of this study is to examine the overall effectiveness of anti-arrhythmic medicines (to control heart rhythm) prescribed after an ablation procedure for atrial fibrillation.

Key facts

Study ID

NCT00408200

Run by

University of Pennsylvania

People needed

110

Starts

2006-11-01

Expected to finish

2008-06-01

Last updated by the study team

2013-03-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients meeting ACC/AHA criteria for paroxysmal atrial fibrillation (episodes typically last no more than 7 days and are self-terminating)
• Eligible for pulmonary vein isolation
• Able to tolerate antiarrhythmic medication

You may not qualify if…

• Age <18
• Persistent or permanent atrial fibrillation (episodes last >7 days and require cardioversion)
• Antiarrhythmic treatment for indication other than atrial fibrillation
• Contraindication or intolerance to all antiarrhythmic medications
• Primary physician unwilling to withhold antiarrhythmic drugs for duration of the study
• Failure to obtain informed consent

Where it is running

• Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Presbyterian Medical Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.